Literature DB >> 19280814

The modified Fontan procedure and prolonged pleural effusions.

Christopher E Mascio1, Matthew Wayment, Tarah T Colaizy, Larry T Mahoney, Harold M Burkhart.   

Abstract

The modified Fontan procedure may be complicated by prolonged pleural drainage. Predisposing factors are not fully understood. This study examines perioperative variables associated with prolonged effusions. We examined the Fontan procedure in 41 patients. Mean age was 45 months (range, 9 to 113 months). Mean weight was 14.7 kg (range, 6.9 to 30.4 kg). Diagnoses included tricuspid atresia in 29 per cent, pulmonary atresia in 12 per cent, and double-outlet right ventricle in 12 per cent. Fontan revisions were excluded. The extracardiac Fontan was performed in 22 patients (54%) and the lateral tunnel (LT) in 18 (44%). Fenestration was performed in 56 per cent. Ten patients (24%) had prolonged pleural effusions. Mean chest tube output (24.2 vs 14.1 mL/kg/d, P < 0.01), days with chest tubes (10.2 vs 5.8 days, P < 0.01), and length of stay (20.8 vs 8.13 days, P < 0.01) were significantly greater in those with effusions. Preoperative mean pulmonary artery pressure was higher in patients with prolonged effusions (12.7 vs 9.90 mmHg, P = 0.001). No other factors were identified as risk factors. Prolonged pleural effusions (greater than 14 days) are common after the modified Fontan procedure. A higher preoperative mean pulmonary artery pressure may be predictive of these effusions. Fenestration, type of Fontan reconstruction, and size of extracardiac conduit did not predispose to postoperative effusions.

Entities:  

Mesh:

Year:  2009        PMID: 19280814

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  10 in total

1.  Outcomes of total cavopulmonary connection for single ventricle palliation.

Authors:  Minghui Zou; Yanfei Wang; Hujun Cui; Li Ma; Shengchun Yang; Yuansheng Xia; Weidan Chen; Xinxin Chen
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

2.  Early Postoperative Albumin Administration Contributes to Morbidity After the Fontan Operation.

Authors:  Hayden J Zaccagni; Jeffrey A Alten; David C Cleveland; R Tyler Argent; Mark A Law; Ayesha S Bryant; Santiago Borasino
Journal:  Pediatr Cardiol       Date:  2016-06-09       Impact factor: 1.655

Review 3.  Hypoplastic left heart syndrome: current considerations and expectations.

Authors:  Jeffrey A Feinstein; D Woodrow Benson; Anne M Dubin; Meryl S Cohen; Dawn M Maxey; William T Mahle; Elfriede Pahl; Juan Villafañe; Ami B Bhatt; Lynn F Peng; Beth Ann Johnson; Alison L Marsden; Curt J Daniels; Nancy A Rudd; Christopher A Caldarone; Kathleen A Mussatto; David L Morales; D Dunbar Ivy; J William Gaynor; James S Tweddell; Barbara J Deal; Anke K Furck; Geoffrey L Rosenthal; Richard G Ohye; Nancy S Ghanayem; John P Cheatham; Wayne Tworetzky; Gerard R Martin
Journal:  J Am Coll Cardiol       Date:  2012-01-03       Impact factor: 24.094

4.  Caval flow reflects Fontan hemodynamics: quantification by magnetic resonance imaging.

Authors:  S Ovroutski; S Nordmeyer; O Miera; P Ewert; K Klimes; T Kühne; F Berger
Journal:  Clin Res Cardiol       Date:  2011-11-18       Impact factor: 5.460

5.  A prospective study of risk factors associated with persistent pleural effusion after total cavopulmonary connection with special reference to serum cortisol level.

Authors:  Sachin Talwar; Anupam Das; Rajesh Khadgawat; Manoj Kumar Sahu; Shiv Kumar Choudhary; Balram Airan
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2017-12-08

6.  Routine Sildenafil Does Not Improve Clinical Outcomes After Fontan Operation.

Authors:  J Leslie Gaddis Collins; Mark A Law; Santiago Borasino; W Clinton Erwin; David C Cleveland; Jeffrey A Alten
Journal:  Pediatr Cardiol       Date:  2017-09-07       Impact factor: 1.655

7.  Safety and Efficacy of Vasopressin After Fontan Completion: A Randomized Pilot Study.

Authors:  Amee M Bigelow; Nancy S Ghanayem; Nathan E Thompson; John P Scott; Laura D Cassidy; Katherine J Woods; Ronald K Woods; Michael E Mitchell; Viktor Hraŝka; George M Hoffman
Journal:  Ann Thorac Surg       Date:  2019-08-07       Impact factor: 5.102

8.  A Randomized, Controlled Pharmacokinetic and Pharmacodynamics Trial of Ambrisentan After Fontan Surgery.

Authors:  Kevin D Hill; Anil R Maharaj; Jennifer S Li; Elizabeth Thompson; Piers C A Barker; Christoph P Hornik
Journal:  Pediatr Crit Care Med       Date:  2020-09       Impact factor: 3.971

Review 9.  Decision-Making for Surgery in the Management of Patients with Univentricular Heart.

Authors:  Ryan Robert Davies; Christian Pizarro
Journal:  Front Pediatr       Date:  2015-07-27       Impact factor: 3.418

10.  Unplanned hospital readmissions following congenital heart diseases surgery. Prevalence and predictors.

Authors:  Ahmad S Azhar
Journal:  Saudi Med J       Date:  2019-08       Impact factor: 1.484

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.